APA

Ladduwahetty T., Baker R., Cascieri M. A., Chambers M. S., Haworth K., Keown L. E., MacIntyre D. E., Metzger J. M., Owen S., Rycroft W., Sadowski S., Seward E. M., Shepheard S. L., Swain C. J., Tattersall F. D., Watt A. P., Williamson D. W. & Hargreaves R. J. (19960906). N-heteroaryl-2-phenyl-3-(benzyloxy)piperidines: a novel class of potent orally active human NK1 antagonists. : Journal of medicinal chemistry.

Chicago

Ladduwahetty T, Baker R, Cascieri M A, Chambers M S, Haworth K, Keown L E, MacIntyre D E, Metzger J M, Owen S, Rycroft W, Sadowski S, Seward E M, Shepheard S L, Swain C J, Tattersall F D, Watt A P, Williamson D W and Hargreaves R J. 19960906. N-heteroaryl-2-phenyl-3-(benzyloxy)piperidines: a novel class of potent orally active human NK1 antagonists. : Journal of medicinal chemistry.

Harvard

Ladduwahetty T., Baker R., Cascieri M. A., Chambers M. S., Haworth K., Keown L. E., MacIntyre D. E., Metzger J. M., Owen S., Rycroft W., Sadowski S., Seward E. M., Shepheard S. L., Swain C. J., Tattersall F. D., Watt A. P., Williamson D. W. and Hargreaves R. J. (19960906). N-heteroaryl-2-phenyl-3-(benzyloxy)piperidines: a novel class of potent orally active human NK1 antagonists. : Journal of medicinal chemistry.

MLA

Ladduwahetty T, Baker R, Cascieri M A, Chambers M S, Haworth K, Keown L E, MacIntyre D E, Metzger J M, Owen S, Rycroft W, Sadowski S, Seward E M, Shepheard S L, Swain C J, Tattersall F D, Watt A P, Williamson D W and Hargreaves R J. N-heteroaryl-2-phenyl-3-(benzyloxy)piperidines: a novel class of potent orally active human NK1 antagonists. : Journal of medicinal chemistry. 19960906.